Aligo Venture Capital is a venture capital firm based in Tczew, Poland, focusing on early-stage investments in HealthTech and CleanTech sectors. They support entrepreneurs addressing global challenges by building valuable companies that reduce the negative impact of the economy on the environment and improve human health through technology. Aligo typically invests between €0.2 million and €0.5 million, often acting as the sole investor or co-financing investment rounds. They frequently become the first investor at the pre-revenue stage, backing founders who start in Poland with ambitions extending beyond national borders.
Is Aligo Venture Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Aligo Venture Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
€200,000 - €500,000
When approaching Aligo Venture Capital, founders should highlight their readiness to scale internationally and demonstrate a clear pathway from early validation to global impact. Emphasize a strong technical foundation and a compelling vision for how your solution can address pressing health or environmental issues at scale. Aligo values founders who can articulate both the societal significance and the commercial potential of their innovations, especially those with a credible plan for navigating the challenges of early-stage growth in regulated or complex markets.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.